
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
Ishwaria Mohan Subbiah, a physician at the MD Anderson Cancer Center, discusses elderly people on clinical trials.
Ishwaria Mohan Subbiah, a physician at the MD Anderson Cancer Center, discusses elderly people on clinical trials.
After observing 1,400 patients on phase 1 clinical trials at MD Anderson Cancer, Subbiah realized that patients over the age of 65 had similarly positive clinical outcomes as younger cohorts. However, she also found that while these older patients make up about half of the new cancer cases each year in the United States, they make up a much smaller proportion of patients enrolled in clinical trials.






